Shun Li Selected Research

4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamide

10/2022

Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shun Li Research Topics

Disease

75	Neoplasms (Cancer) 11/2022 - 03/2004
21	Infections 01/2022 - 01/2012
16	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2015
14	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2004
12	Viremia 01/2022 - 01/2012
12	Virus Diseases (Viral Diseases) 01/2022 - 01/2012
9	Ischemic Stroke 02/2021 - 12/2018
8	Stroke (Strokes) 01/2021 - 01/2019
7	Glioma (Gliomas) 12/2019 - 11/2013
6	Carcinogenesis 05/2022 - 12/2015
5	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 01/2019
5	Carcinoma (Carcinomatosis) 01/2022 - 12/2009
5	Melanoma (Melanoma, Malignant) 12/2019 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
4	Reperfusion Injury 01/2017 - 11/2014
3	Type 2 Diabetes Mellitus (MODY) 05/2022 - 04/2007
3	COVID-19 01/2022 - 01/2021
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2021 - 12/2018
3	Hypoxia (Hypoxemia) 01/2020 - 07/2014
3	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 12/2015
2	Schistosomiasis japonica 01/2022 - 12/2020
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Leukoaraiosis 11/2020 - 02/2019
2	Pain (Aches) 10/2020 - 10/2013
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2020
2	Zika Virus Infection 12/2019 - 10/2017
2	Atherosclerosis 01/2019 - 01/2019
2	Underactive Urinary Bladder 10/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2015
12	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2012
11	Pharmaceutical PreparationsIBA 07/2022 - 01/2017
10	InterferonsIBA 01/2022 - 01/2012
10	Poly I-CIBA 01/2021 - 01/2012
7	Small Interfering RNA (siRNA)IBA 11/2022 - 01/2017
7	CytokinesIBA 01/2022 - 02/2012
6	Caveolin 1IBA 01/2022 - 03/2016
6	Biological ProductsIBA 01/2022 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2004
5	Transcription Factors (Transcription Factor)IBA 10/2020 - 10/2016
4	Therapeutic UsesIBA 03/2022 - 01/2017
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2016
4	LipidsIBA 01/2022 - 09/2019
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 07/2015
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2020 - 01/2012
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
3	MicellesIBA 10/2022 - 01/2019
3	CopperIBA 05/2022 - 01/2012
3	Long Noncoding RNAIBA 05/2022 - 10/2021
3	Glutathione (Reduced Glutathione)IBA 03/2022 - 01/2019
3	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 01/2017
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2020
3	Adenosine Triphosphate (ATP)IBA 11/2021 - 01/2017
3	RNA (Ribonucleic Acid)IBA 10/2021 - 12/2020
3	AcidsIBA 01/2021 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 01/2012
3	IntegrinsIBA 01/2020 - 07/2018
3	GraphiteIBA 01/2020 - 01/2017
3	Angiopep-2IBA 12/2019 - 11/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 02/2018 - 02/2012
3	LigandsIBA 04/2016 - 11/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022 - 10/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022 - 01/2022
2	AntigensIBA 10/2022 - 11/2020
2	ChromatinIBA 05/2022 - 01/2021
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	Viral RNAIBA 01/2022 - 01/2017
2	erucylphosphocholineIBA 01/2022 - 01/2012
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	polyacrylamideIBA 01/2022 - 01/2019
2	Singlet OxygenIBA 11/2021 - 05/2017
2	Hyaluronic Acid (Hyaluronan)IBA 11/2021 - 01/2019
2	CateninsIBA 11/2021 - 12/2019
2	Contrast MediaIBA 01/2021 - 08/2018
2	UbiquitinIBA 12/2020 - 01/2019
2	Transforming Growth Factor-beta Type II ReceptorIBA 11/2020 - 11/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020 - 11/2020
2	PolymersIBA 09/2020 - 05/2020
2	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2020 - 10/2018
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020 - 01/2020
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 12/2019 - 01/2019
2	GoldIBA 09/2019 - 01/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 05/2017
2	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019 - 01/2018
2	HMGB1 Protein (HMG1)IBA 11/2018 - 07/2014
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2018 - 03/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018 - 04/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 10/2015

Therapy/Procedure

30	Therapeutics 03/2022 - 01/2017
8	Immunotherapy 10/2022 - 02/2018
8	Precision Medicine 01/2022 - 01/2017
8	Thrombectomy 02/2021 - 12/2018
7	Drug Therapy (Chemotherapy) 10/2021 - 10/2016
6	Lasers (Laser) 11/2021 - 01/2017
4	Photothermal Therapy 01/2020 - 01/2017
3	Radiotherapy 12/2019 - 10/2016